Published in Am J Pathol on August 19, 2010
Exploiting replicative stress to treat cancer. Nat Rev Drug Discov (2015) 1.27
Molecular architecture of the DNA replication origin activation checkpoint. EMBO J (2010) 1.04
Tethering of SCF(Dia2) to the Replisome Promotes Efficient Ubiquitylation and Disassembly of the CMG Helicase. Curr Biol (2015) 0.90
Identification of potential synthetic lethal genes to p53 using a computational biology approach. BMC Med Genomics (2013) 0.87
p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress. Cell Cycle (2016) 0.85
Xenopus Cdc7 executes its essential function early in S phase and is counteracted by checkpoint-regulated protein phosphatase 1. Open Biol (2014) 0.85
Subcellular proteomics reveals a role for nucleo-cytoplasmic trafficking at the DNA replication origin activation checkpoint. J Proteome Res (2013) 0.83
Mechanism of cancer cell death induced by depletion of an essential replication regulator. PLoS One (2012) 0.83
Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint. Oncotarget (2016) 0.82
3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors. ACS Med Chem Lett (2011) 0.78
Quantitative proteomics reveals a "poised quiescence" cellular state after triggering the DNA replication origin activation checkpoint. J Proteome Res (2010) 0.78
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer. Diagn Pathol (2015) 0.77
The role of Dbf4-dependent protein kinase in DNA polymerase ζ-dependent mutagenesis in Saccharomyces cerevisiae. Genetics (2014) 0.77
Molecular genetic study of novel biomarkers for early diagnosis of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal (2015) 0.77
Candida albicans Dbf4-dependent Cdc7 kinase plays a novel role in the inhibition of hyphal development. Sci Rep (2016) 0.75
Cell division cycle 7-kinase inhibitor PHA-767491 hydrochloride suppresses glioblastoma growth and invasiveness. Cancer Cell Int (2016) 0.75
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer (1957) 21.59
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol (1999) 11.18
Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol (2002) 4.50
Trastuzumab in the treatment of breast cancer. N Engl J Med (2005) 3.86
Right place, right time, and only once: replication initiation in metazoans. Cell (2005) 3.61
The lifetime risk of developing breast cancer. J Natl Cancer Inst (1993) 3.33
Replication licensing and cancer--a fatal entanglement? Nat Rev Cancer (2008) 2.86
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol (2005) 2.70
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res (2006) 2.69
Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell (1997) 2.67
Eukaryotic DNA replication control: lock and load, then fire. Curr Opin Cell Biol (2009) 2.45
The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses. Mol Cell Biol (2007) 2.41
Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol (2009) 2.20
Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J Biol Chem (2006) 2.04
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat (2007) 1.84
Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med (2005) 1.57
Identification of CDK2 substrates in human cell lysates. Genome Biol (2008) 1.52
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res (2005) 1.50
Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells. Cancer Res (2004) 1.37
The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer (2008) 1.35
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer. J Clin Oncol (2003) 1.28
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat (2009) 1.23
DNA replication licensing in somatic and germ cells. J Cell Sci (2004) 1.21
Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer (2007) 1.17
Prognostic and predictive molecular markers in DCIS: a review. Adv Anat Pathol (2005) 1.14
Targeted therapies in breast cancer: where are we now? Eur J Cancer (2008) 1.14
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer (2005) 1.12
Cell cycle markers in clinical oncology. Curr Opin Cell Biol (2007) 1.12
1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal Cell Pathol (1998) 1.11
Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team. Eur J Surg Oncol (2001) 1.11
Cdc7 kinase - a new target for drug development. Eur J Cancer (2010) 1.09
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. Exp Cell Res (2005) 1.07
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer (2009) 1.04
Targeted therapies for the treatment of breast cancer in the post-trastuzumab era. Oncologist (2008) 1.01
Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res (2009) 0.98
Targeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonists. Int J Gynecol Cancer (2006) 0.96
DNA replication licensing and cell cycle kinetics of oligodendroglial tumours. Br J Cancer (2004) 0.96
DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin Cancer Res (2007) 0.95
Control of DNA replication: regulation and activation of eukaryotic replicative helicase, MCM. IUBMB Life (2005) 0.93
Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer. Breast Cancer Res (2009) 0.89
Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet (2012) 6.81
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med (2012) 5.21
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer. J Clin Oncol (2011) 3.73
Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med (2012) 3.01
Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet (2008) 2.98
Intraoperative radiotherapy for breast cancer. Lancet Oncol (2004) 2.91
Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ (2012) 2.66
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ (2008) 2.25
Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med (2010) 2.04
The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health (2009) 1.83
The cell cycle and cancer. J Pathol (2011) 1.67
Randomised crossover trial comparing the performance of Clinical Terms Version 3 and Read Codes 5 byte set coding schemes in general practice. BMJ (2003) 1.62
Small-molecule mimics of an alpha-helix for efficient transport of proteins into cells. Nat Methods (2007) 1.61
A needs-based study and examination skills course improves students' performance. Med Educ (2003) 1.58
Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity. Ann Behav Med (2014) 1.58
Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes? Ann Behav Med (2015) 1.56
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst (2004) 1.55
Randomized controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit). Nicotine Tob Res (2012) 1.52
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial. BMJ (2010) 1.52
Expansion of the red cell distribution width and evolving iron deficiency as predictors of poor outcome in chronic heart failure. Int J Cardiol (2013) 1.52
The ProActive trial protocol - a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766]. BMC Public Health (2004) 1.51
Fidelity of delivery of a physical activity intervention: predictors and consequences. Psychol Health (2008) 1.51
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial. BMJ (2012) 1.51
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res (2005) 1.50
Tolerance of early diet textures as indicators of recovery from dysphagia after stroke. Dysphagia (2002) 1.49
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst (2002) 1.48
Older patients with hip fractures: evaluation of a long-term specialist orthopaedic medicine service in their outcomes. N Z Med J (2007) 1.47
Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. Br J Gen Pract (2013) 1.45
Late onset congenital central hypoventilation syndrome after exposure to general anesthesia. Can J Anaesth (2011) 1.42
An evaluation by doctors in training of a pilot programme of physician assistants. Hosp Med (2004) 1.40
Older patients in the nephrology clinic--should they be referred? N Z Med J (2005) 1.39
What is the effect of a consultant presence in an acute medical unit? Clin Med (2009) 1.39
Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol (2011) 1.35
Breast cancer: multidisciplinary care and clinical outcomes. Eur J Cancer (2006) 1.33
Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. Respirology (2011) 1.32
Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer (2006) 1.30
Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax (2006) 1.24
Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study. J Thorac Oncol (2011) 1.23
DNA replication licensing in somatic and germ cells. J Cell Sci (2004) 1.21
Commitment point during G0-->G1 that controls entry into the cell cycle. Mol Cell Biol (2003) 1.21
Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Natl Acad Sci U S A (2011) 1.18
Stochastic homeostasis in human airway epithelium is achieved by neutral competition of basal cell progenitors. Elife (2013) 1.15
Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J Biol Chem (2004) 1.14
Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer. J Natl Cancer Inst (2009) 1.13
Impact of body mass index on prevalence of multimorbidity in primary care: cohort study. Fam Pract (2013) 1.13
Elastic scattering spectroscopy for intraoperative determination of sentinel lymph node status in the breast. J Biomed Opt (2004) 1.13
Cell cycle markers in clinical oncology. Curr Opin Cell Biol (2007) 1.12
Influences on the variation in prevalence of type 2 diabetes between general practices: practice, patient or socioeconomic factors? Br J Gen Pract (2003) 1.11
Hexameric ring structure of human MCM10 DNA replication factor. EMBO Rep (2007) 1.10
Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. BMC Public Health (2008) 1.10
Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care (2009) 1.08
Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells. Exp Cell Res (2005) 1.07
Molecular architecture of the DNA replication origin activation checkpoint. EMBO J (2010) 1.04
Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials. Stat Med (2004) 1.04
Validity of smoking prevalence estimates from primary care electronic health records compared with national population survey data for England, 2007 to 2011. Pharmacoepidemiol Drug Saf (2013) 1.04
Biomarkers in bladder cancer. Histopathology (2010) 1.04
An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract (2012) 1.03
Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health (2011) 1.01
Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn's disease activity: a preliminary study. Eur Radiol (2012) 1.01
Randomized controlled trial to assess the short-term effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care (iQuit in practice). Addiction (2014) 1.01
Circulating tumor cells and EpCAM expression in neuroendocrine tumors. Clin Cancer Res (2011) 1.01
Investigating theoretical explanations for behaviour change: the case study of ProActive. Psychol Health (2008) 0.99
Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis. Retina (2013) 0.99
Management of lower limb complex regional pain syndrome type 1: an evaluation of percutaneous radiofrequency thermal lumbar sympathectomy versus phenol lumbar sympathetic neurolysis--a pilot study. Anesth Analg (2008) 0.98
Self-help smoking cessation interventions in pregnancy: a systematic review and meta-analysis. Addiction (2008) 0.98
Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma. Clin Cancer Res (2009) 0.98
Protocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication. BMC Fam Pract (2008) 0.97
Evaluation of the MoleMate training program for assessment of suspicious pigmented lesions in primary care. Inform Prim Care (2008) 0.96
DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin Cancer Res (2007) 0.95
Scanning elastic scattering spectroscopy detects metastatic breast cancer in sentinel lymph nodes. J Biomed Opt (2010) 0.95
Epidemiology of clinical body mass index recording in an obese population in primary care: a cohort study. J Public Health (Oxf) (2012) 0.93
Evaluation of an informed choice invitation for type 2 diabetes screening. Patient Educ Couns (2008) 0.93
Perceptions of absolute versus relative differences between personal and comparison health risk. Health Psychol (2008) 0.93